Found: 8
Select item for more details and to access through your institution.
Safety, tolerability and immunogenicity of an active anti‐Aβ40 vaccine (ABvac40) in patients with amnestic mild cognitive impairment (A‐MCI) or very mild alzheimer's disease (VM‐AD): A randomized, double‐blind, placebo‐controlled, phase II trial: Human/Human trials: Anti‐amyloid
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045720
- By:
- Publication type:
- Article
P4‐189: ABVAC40 TREATMENT IN DOGS INDUCES SPECIFIC ANTIBODY RESPONSE AND INCREMENT OF Aβ40 LEVELS IN PLASMA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1512, doi. 10.1016/j.jalz.2018.06.2594
- By:
- Publication type:
- Article
ANTI-AβX-40 ANTIBODIES EXERT NEUROPROTECTIVE EFFECT AGAINST Aβ-OLIGOMER TOXICITY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1439, doi. 10.1016/j.jalz.2017.06.2255
- By:
- Publication type:
- Article
AN ACTIVE ANTI-AB40 VACCINE (ABVAC40) PROVED TO BE SAFE AND IMMUNOGENIC IN THE PHASE I CLINICAL TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P199, doi. 10.1016/j.jalz.2016.06.348
- By:
- Publication type:
- Article
Beta-amyloid-17 is a major beta-amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value
- Published in:
- 2012
- By:
- Publication type:
- Abstract
The deposition of Aß40 in the brain is pathognomonic for Alzheimer-type dementia in Down syndrome
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P4-157: Neurofibrillary tangles of Aβ40 in Alzheimer brains
- Published in:
- 2008
- By:
- Publication type:
- Abstract
AB1601 topline results – Phase 2 study of ABvac40 in patients with amnestic mild cognitive impairment (a‐MCI) or very mild Alzheimer's Disease (Vm‐AD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.065633
- By:
- Publication type:
- Article